Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Sees Growth Opportunities Through Partnerships And Emerging Markets After Facing Early Patent Cliff

Executive Summary

Johnson & Johnson is increasingly looking to partnerships as part of its strategy to bounce back from the onset of generic competition for its mega drugs Risperdal Oral (risperidone) and Topamax (topiramate)

You may also be interested in...



J&J Strengthens Diabetes Pipeline With Two Deals

A late-stage deal for a type 1 treatment and an early-stage deal for a series of type 2 compounds help J&J's move into diabetes, where it has traditionally been strong in blood glucose monitoring.

J&J Strengthens Diabetes Pipeline With Two Deals

A late-stage deal for a type 1 treatment and an early-stage deal for a series of type 2 compounds help J&J's move into diabetes, where it has traditionally been strong in blood glucose monitoring.

Device Firms Stand To Lose Market Opportunities If Health Care Reform Dies

With the fate of comprehensive health care reform in serious doubt at the eleventh hour, many in the device industry may be breathing a sigh of relief that the device tax could be avoided or at least lessened. But if the reform bill dies, the industry will also lose out on the potential 30 million additional health care customers slated to gain insurance under its provisions

Related Content

Topics

UsernamePublicRestriction

Register

PS051889

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel